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Abstract
Pyrrolizidine alkaloids (PA) are secondary plant metabolites that occur as food and feed contaminants. Acute and subacute 
PA poisoning can lead to severe liver damage in humans and animals, comprising liver pain, hepatomegaly and the devel-
opment of ascites due to occlusion of the hepatic sinusoids (veno-occlusive disease). Chronic exposure to low levels of PA 
can induce liver cirrhosis and liver cancer. However, it is not well understood which transcriptional changes are induced by 
PA and whether all hepatotoxic PA, regardless of their structure, induce similar responses. Therefore, a 28-day subacute rat 
feeding study was performed with six structurally different PA heliotrine, echimidine, lasiocarpine, senecionine, senkirkine, 
and platyphylline, administered at not acutely toxic doses from 0.1 to 3.3 mg/kg body weight. This dose range is relevant 
for humans, since consumption of contaminated tea may result in doses of ~ 8 µg/kg in adults and cases of PA ingestion by 
contaminated food was reported for infants with doses up to 3 mg/kg body weight. ALT and AST were not increased in all 
treatment groups. Whole-genome microarray analyses revealed pronounced effects on gene expression in the high-dose 
treatment groups resulting in a set of 36 commonly regulated genes. However, platyphylline, the only 1,2-saturated and, 
therefore, presumably non-hepatotoxic PA, did not induce significant expression changes. Biological functions identified to 
be affected by high-dose treatments (3.3 mg/kg body weight) comprise cell-cycle regulation associated with DNA damage 
response. These functions were found to be affected by all analyzed 1,2-unsaturated PA.
In conclusion, 1,2-unsaturated hepatotoxic PA induced cell cycle regulation processes associated with DNA damage response. 
Similar effects were observed for all hepatotoxic PA. Effects were observed in a dose range inducing no histopathological 
alterations and no increase in liver enzymes. Therefore, transcriptomics studies identified changes in expression of genes 
known to be involved in response to genotoxic compounds at PA doses relevant to humans under worst case exposure 
scenarios.
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Introduction
Pyrrolizidine alkaloids (PA) are a group of secondary plant 
metabolites that belong to the most widely distributed nat-
ural toxins. PA can contaminate food and feed and, thus, 
may affect health of consumers, livestock and wildlife 
(Stegelmeier et al. 1999; Wiedenfeld 2011). In Germany 
and Europe, tea, honey and herbal spices were identified 
as the main sources contributing to human exposure to 
PA (BfR 2018; BfR 2019; Bodi et al. 2014; EFSA 2017; 
Mulder et al. 2018). The European Food Safety Authority 
and the German Federal Institute for Risk Assessment con-
cluded that uptake of contaminated food from the Euro-
pean Market may pose a risk to human health, especially 
for people consuming high amounts of these products, and 
for children (BfR 2018; BfR 2019; EFSA 2017).
PA share a common basic structure. They consist of 
a 1-hydroxymethylpyrrolizidine (necine base) esterified 
with one or two aliphatic mono- or dicarboxylic acids, so-
called necine acids. According to their necine base, they 
are divided into four different structure types: retronecine-, 
heliotridine-, otonecine- and platynecine-type PA. Fur-
thermore, they can be grouped according to their degree 
of esterification into monoesters, non-cyclic diesters and 
cyclic diesters. Due to different combinations of different 
necine bases and necine acids, a wide variety of structur-
ally different PA congeners exists. Today, several hundred 
PA are known; probably produced by more than 6000 plant 
species (Stegelmeier et al. 1999). Oxidation of the nitrogen 
atom at one bridgehead of the two fused pentagonal car-
bon rings leads to PA N-oxides. PA N-oxides show higher 
water solubility compared to the free bases, and, thus, the 
N-oxide type is the predominating form in plants (Wieden-
feld et al. 2008). Since PA N-oxides can be reduced to the 
free base form, it is considered that PA N-oxides and free 
PA exert comparable toxicity (Wiedenfeld et al. 2008). 
Figure 1 summarizes the structure of the PA representa-
tives used in this study and assigns them to their respective 
structure type.
While the retronecine-, heliotridine- and otonecine-
type PA are based on a 1,2-unsaturated necine base, the 
platynecine type lacks this double bond in 1,2-position. The 
1,2-double bond is required for toxicity. Therefore, platyne-
cine-type PA are assumed to be non-toxic. Further require-
ments for toxicity are described as follows: (i) at least one 
hydroxyl group needs to be attached to the pyrrolizidine ring 
via one carbon atom, (ii) at least one of this hydroxyl groups 
needs to be esterified, and (iii) the acid moiety needs to have 
a branched chain (Mattocks 1986). Toxicity is assumed to 
increase from monoesters to non-cyclic diesters and finally 
cyclic diesters with heliotridine-type PA being more toxic 
compared to retronecine-type PA (Merz and Schrenk 2016). 
It is considered that toxicity is not based on the PA par-
ent compounds themselves but on their metabolites formed 
during bioactivation reactions located mainly in the liver. 
Hepatic metabolism is initiated by a cytochrome P450 
(CYP)-mediated oxidation followed by spontaneous dehy-
dration. Resulting pyrrolic esters are highly reactive and able 
to form protein and DNA adducts as well as DNA/protein 
cross-links which are assumed to be responsible for toxicity 
(Mattocks 1986; Ruan et al. 2014; Wiedenfeld et al. 2008).
Consumption of PA-contaminated food may lead to 
severe liver failure. Several case studies report the devel-
opment of veno-occlusive disease after uptake of highly 
PA-contaminated wheat flour, seeds or herbal tea (Bras 
et al. 1954; Datta et al. 1978; Kakar et al. 2010; Mohabbat 
et al. 1976; Tandon et al. 1976). Furthermore, genotoxic, 
carcinogenic and pneumotoxic properties of PA have been 
described (Culvenor et al. 1969; Fu et al. 2004; Moreira 
et al. 2018). Some studies also point to the development of 
cholestasis (Hessel-Pras et al. 2020; Luckert et al. 2015). 
However, most of these specific effects were observed in 
the high-dose range. Our study aimed to identify toxic 
Fig. 1  Structure of the PA representatives senecionine, echimidine, heliotrine, lasiocarpine, senkirkine and platyphylline used in this study. 
These six PA representatives cover the different necine structure types as well as the different degrees of esterification.
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effects in a non-acute toxic dose range reflecting human 
exposure scenarios over a time period of 28 days to display 
repeated exposure and to achieve substantial responses on 
gene expression level in the low dose range. Furthermore, 
we wanted to test if structurally different PA affect different 
pathways or result in a similar toxicity pattern. Therefore, 
we chose a whole-genome transcriptomic approach in male 
Fischer rats treated by gavage with the PA representatives 
echimidine, heliotrine, lasiocarpine, senecionine, senkirkine 
and platyphylline covering all existing necine base structure 
types as well as monoesters, non-cyclic and cyclic diesters. 
Platyphylline is considered to be non-hepatotoxic due to the 




Echimidine (94% purity), heliotrine (91% purity), lasiocar-
pine (98% purity), senecionine (99% purity) and senkirkine 
(98% purity) were purchased from PhytoLab (Verstenbergs-
greuth, Germany). Platyphylline (95% purity) was purchased 
from BOC Sciences (New York, New York, USA). Senecio-
nine was dissolved in 0.2-M hydrochloric acid. Afterwards, 
pH was adjusted to 6–7 using 0.2-M sodium hydroxide solu-
tion. Sodium chloride (NaCl) was added to obtain a solution 
containing 0.15-M NaCl. All other PA were dissolved in 
0.15-M aqueous NaCl solution.
Animal experiments
A 28-day oral toxicity study was performed with male Fis-
cher rats (strain F-344/DuCrl) exposed to six PA, namely 
echimidine, heliotrine, lasiocarpine, senecionine, senkirkine 
and platyphylline at the Fraunhofer Institute for Toxicology 
and Experimental Medicine (ITEM, Hanover, Germany). 
All animal experiments were conducted in compliance with 
the regulation of the German Animal Protection Law, fol-
lowing the principles of Good Laboratory Practice (OECD 
1998) and considering OECD Guideline 407 for repeated 
dose 28-day oral toxicity study in rodents (adopted guide-
line; October 3, 2008).
A total of 128 male Fischer rats (strain F-344/DuCrl) 
were purchased from Charles River Deutschland (Sulzfeld, 
Germany) and divided into 25 groups. Grouping was per-
formed randomly according to the average body weight 
of the animals resulting in groups with the same average 
body weight. Each treatment group consisted of five ani-
mals. Vehicle control included 8 animals. Following deliv-
ery, the 4–5-week-old animals were allowed to acclimatize 
for 4 weeks; at study start (i.e., at an age of 8–9 weeks), 
body weights of about 200 g were determined. Animals 
were group-housed in type IV Makrolon® (polycarbon-
ate) cages and maintained under conventional laboratory 
conditions. The temperature (22 ± 2 °C) and the relative 
humidity (55 ± 15%) of the animal room were monitored 
and recorded continuously. A 12-h light/dark cycle was used. 
Rats had access to commercial diet (Ssniff V1534, Ssniff-
Spezialdiäten, Soest, Germany) and tap water ad libitum. 
Animals were treated for 28 days daily by gavage with a 
flexible tube. A solution of 0.15-M NaCl served as vehicle 
control (group 1). Groups 2–25 were treated with 0.1, 0.33, 
1.0, or 3.3 mg/kg body weight (bw) of single PA. Informa-
tion about animal treatment is summarized in Table 1. Doses 
were chosen following a two-week and 13-week NTP study 
with riddelliine in Fischer rats (National Institutes of Health 
1993). According to the publication of Merz and Schrenk 
(2016), the cyclic retronecine-type diester riddelliine exhib-
its comparable potency like senecionine which was used in 
this study. A dose of 3.3 mg/kg bw was chosen as the high-
est dose to avoid unspecific effects resulting from general 
toxicity.
Throughout the study, individual body weight was 
recorded once a week. Additionally, animals were observed 
daily for clinical symptoms. One day after the last admin-
istration, animals were killed and prepared for histopatho-
logical examination of lungs and livers, blood analysis and 
transcriptomic analysis. Animals were killed by a lethal dose 
of pentobarbital. A total of approximately 3-ml heparinized 
blood (+ Nembutal) was collected from the vena cava cau-
dalis before start of whole-body perfusion for liver prepara-
tion. Liver weights were determined.
Histopathological examination and analysis 
of transaminases in blood
One slice with a maximal diameter of 7 mm of the rat liver 
lobes 1 and 3 was fixed in buffered formalin (10%), embed-
ded in paraffin, sectioned, and stained with hematoxylin and 
eosin. Levels of the transaminases aspartate aminotrans-
ferase and alanine aminotransferase in blood were analyzed 
Table 1  Summary of animal treatment
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by kinetic UV test at 37 °C as described before (Bergmeyer 
1983).
Transcriptomics analysis
For transcriptomics analysis of liver, RNA was extracted 
using the RNeasy Mini Kit (Qiagen, Hilden, Germany) 
in combination with QiaShredder (Qiagen, Hilden, Ger-
many). Thus, small pieces of the deep-frozen liver lobe 1 
were homogenized under liquid nitrogen and transferred 
to RLT buffer (Qiagen, Hilden, Germany) containing 1% 
β-mercaptoethanol. Afterwards, the lysate was further 
homogenized using QiaShredder and the RNA was isolated 
using RNeasy Mini Kit according to the Manufacturer’s 
instructions. Concentration and purity of total RNA was 
measured at a Tecan M200Pro spectrophotometer using a 
NanoQuant Plate at wavelengths of 260 nm and 280 nm, 
and on an Agilent 2100 BioAnalyzer (Agilent, Santa Clara, 
California, USA). Only high-quality RNA with RNA integ-
rity numbers (RIN) higher than 9 were used for microarray 
analysis. Microarray analysis was performed at Eurofins 
(Aarhus, Denmark) using Affymetrix GeneChip Rat Clari-
omD arrays (Thermo Fisher Scientific, Waltham, Massa-
chusetts, USA). The raw data of this publication have been 
deposited in NCBI’s Gene Expression Omnibus (Edgar et al. 
2002) and are accessible through GEO Series accession 
number GSE149678.
Verification of microarray results by qPCR
Extracted RNA was analyzed by quantitative real-time PCR 
(qPCR) for the expression of the following genes to validate 
microarray results: Abcb1b, Aldh1a1, Ckap2, Fas, Clec4f, 
Csf1r and Inmt. The first 4 genes were found to be signifi-
cantly (q < 0.05) upregulated in microarray analysis. The last 
three genes were significantly (q < 0.05) downregulated. The 
genes were randomly chosen among the genes that were dys-
regulated by at least 3 out of 5 toxic PA. Gapdh and Actb 
were used as housekeeping genes. Extraction of RNA was 
performed as described for transcriptomics analysis (see 
Sect. “Transcriptomics analysis”). Afterwards, cDNA syn-
thesis was conducted with 1000-ng RNA using the High 
Capacity cDNA Reverse Transcription Kit according to the 
manufacturer’s instructions (Applied Biosystems, Foster 
City, California, USA). qPCR was performed using Maxima 
SYBR Green/ROX qPCR Master Mix (Thermo Fisher Sci-
entific, Waltham, Massachusetts, USA) with 1 µl of cDNA 
and 300 pmol of the respective forward and reverse primers 
on a Stratagene Mx3005P instrument (Agilent Technologies, 
Santa Clara, California, USA). Gene names, gene abbrevia-
tions, and used primer sequences are summarized in Table 2. 
All primers were designed using Primer3 software (Rozen 
and Skaletsky 2000). For thermal cycling procedure, an ini-
tial denaturation and activation of the hot start Taq polymer-
ase at 95 °C for 15 min was followed by 40 cycles consisting 
of denaturation (95 °C, 15 s) and annealing and elongation 
(60 °C, 1 min). Finally, final elongation was performed for 
15 min at 60 °C. Additionally, a dissociation curve step was 
added.
Statistical and bioinformatic data analysis
For statistical analysis, microarray data were normalized 
using the robust multi-array-average (RMA) function of 
the limma (linear models for microarray and RNA-Seq 
data) package (Smyth et al. 2019, page 104) in R (R Core 
Team 2017; Ritchie et al. 2015) to assure that any batch 
effects between arrays are being removed. Subsequently, 
the dataset was filtered and only transcripts were kept for 
which annotations were available. The reduced dataset 
Table 2  Primer sequences used 
in this study
1 Gene names: Abcb1 ATP-binding cassette subfamily B member 1, Actb actin beta, Aldh1a1 aldehyde 
dehydrogenase 1 family member A1, Ckap2 cytoskeleton-associated protein 2, Clec4 C-type lectin domain 
family 4, Csf1r colony stimulating factor 1 receptor, Fas fas cell surface death receptor, Gapdh glyceralde-
hyde-3-phosphate dehydrogenase, Inmt indolethylamine N-methyltransferase
Gene1 Sequence (5′–3′)
Forward primer Reverse primer
Abcb1b TGG CCA TGT ACG CCT ACT ATT ACA AAA ACC GGC TGA AAA TGT CGTT 
Actb TGT GTT GTC CCT GTA TGC CT AGC GCG TAA CCC TCA TAG AT
Aldh1a1 GAT GCC GAC TTG GAC ATT GC GAC GCA GCA TTG GCC TTG AT
Ckap2 TAA TGC CAG GCT GAC AGG AA GCT GTG GTA TCT TTG GGC TG
Clec4f ATG AAG GAG GCG GAA CTG AA ATG GGA GCA GCT GAC TTA GG
Csf1r CAA ACT CCA CCT GAA CCG TG TAT CGC AGG GTG AGC TCA AA
Fas ACA TCT GGA GAA CTG CCG AA CAT CGA TCT TGC TTT CCG GG
Gapdh CCG TGG GGC AGC CCA GAA GCC CCA GCA TCA AAG GTG GAGGA 
Inmt ACT AGA ATG GCA GGC AAG GT GCT GTA GAA GGT GGT CAG GT
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comprising 26,480 probe sets was analyzed further using 
Qlucore Omics Explorer (version 3.3, Qlucore, Lund, 
Sweden). The short technical note on the use of Qlucore 
for omics data mining gives a short summary of how the 
analysis workflow employed in the present study has been 
used to reduce large number of altered genes to a few 
robust discriminative features (Rasinger and Lie). After 
a correction for batch-dependent differences of microar-
ray chips, a comparison of all high-dose groups of single 
PA was performed using one-way analysis of variance 
(ANOVA). Fold changes for significantly dysregulated 
genes (q < 0.05) were determined using two-group com-
parison tests against vehicle control. The q-values are 
Benjamini–Hochberg-corrected p-values as outputted by 
Qlucore (Benjamini and Hochberg 1995) to control the 
false discovery rate. In addition, rank regressions were 
performed across all doses for each individual PA.
Following statistical analysis, data was subjected to Inge-
nuity Pathway Analysis (IPA, version 48,207,413, Qiagen 
Bioinformatics, Redwood City, California, USA). Compari-
son analyses to predict affected canonical pathways, diseases 
and functions and upstream regulators were performed.
Data regarding body weight, relative liver weight, levels 
of transaminases were recorded and analyzed by one-way 
ANOVA followed by Dunnett’s post hoc test using the PRO-
VANTIS system (version 8.4.3.1). Relative gene expression 
as analyzed by qPCR was statistically analyzed by one-way 
ANOVA followed by Dunnett’s post hoc test using Sigma-
Plot software.
Results
Body weights, organ weights and transaminases 
in blood
No differences in body weight development of treated ani-
mals compared to the vehicle control were observed. Indi-
vidual data are summarized in supplementary data Figure 
S1. Absolute liver weights did also not show relevant dif-
ferences between vehicle control and treatment groups. The 
high-dose senkirkine treatment group showed a slightly but 
significantly increased relative liver weight (111% of vehicle 
control, p < 0.05) (Supplementary data, Fig. S2).
The levels of the hepatic enzymes aspartate aminotrans-
ferase (AST) and alanine aminotransferase (ALT) were 
determined in blood to identify hepatotoxicity. All groups 
did not show statistically significant (p < 0.05) changes in 
neither ALT nor AST levels, except the high-dose group of 
lasiocarpine (3.3 mg/kg bw) which showed a statistically 
significant (p < 0.05) increase of ALT from 85.8 ± 22.5 U/l 
in control animals to 160.5 ± 19.4 U/l (Supplementary data 
Fig. S3). However, no morphological changes were detected 
in this group during histopathological examination (see 
“Histopathology”).
Histopathology
The livers of all animals were examined histopathologically. 
A (multi)focal random mixed inflammatory cell infiltration 
as well as (multi)focal periportal mononuclear cell infiltra-
tion were seen to a very slight extent in up to two animals per 
group in most groups (Supplementary data Fig. S4). Within 
the senecionine high-dose group (3.3 mg/kg bw), four ani-
mals showed a (multi)focal random mixed inflammatory cell 
infiltration (3/5 very slight and 1/5 slight). However, these 
lesions occur occasionally in rats and are considered to be 
unrelated to the treatment.
Taken together, results of biochemical analysis showed 
only weak effects for lasiocarpine in the highest dose group 
by inducing a twofold increase in ALT activity. This sug-
gests that the chosen dose range represents doses in the 
borderline range for classic toxicity and, thus, may be in 
the range of or below the no-observed adverse effect levels 
(NOAEL). Therefore, it is assumed that the changes in the 
following gene expression analysis are PA-specific effects 
instead of unspecific effects resulting from massive injury 
of the whole organism.
Whole‑genome microarray analysis
A whole-genome microarray analysis was performed to 
identify PA-affected pathways in dependence of the PA 
structure type. For statistical evaluation, the whole dataset 
including 70,580 probe sets was reduced to 26,480 annotated 
probe sets and an ANOVA between all high-dose groups 
and vehicle control was performed. This resulted in 284 sig-
nificantly altered (q < 0.05) probe sets (see Supplementary 
data, Table S1). Hierarchical clustering of these transcripts 
according to the PA exposure groups is shown in Fig. 2a.
Platyphylline as a non-hepatotoxic PA showed a gene 
expression pattern very similar to the vehicle control up to 
the highest tested dose of 3.3 mg/kg bw. Senkirkine showed 
the strongest alterations compared to the vehicle control, 
followed by senecionine. Heliotrine and lasiocarpine showed 
alterations of moderate magnitude between platyphylline 
and senecionine/senkirkine. Echimidine was the treat-
ment group with the highest variability in the magnitude 
of alterations between the different individuals. To identify 
the direction of regulation, significantly differentially regu-
lated (q < 0.05, ANOVA) probe sets were analyzed further 
performing two-group comparisons of each PA against the 
vehicle control. The number of up- and downregulated probe 
sets is shown in Fig. 2b. Most of the dysregulated genes were 
upregulated. Again, senecionine and senkirkine showed the 
1744 Archives of Toxicology (2020) 94:1739–1751
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highest numbers of significantly dysregulated probe sets. 
Platyphylline, a PA representative assumed to be non-hepa-
totoxic, provoked significant regulation of only 11 probe sets 
in total. The Venn diagram in Fig. 2c shows the overlap of 
similar dysregulated probe sets for the different PA. In total, 
a signature of 36 dysregulated probe sets corresponding to 
35 individual genes was identified to be dysregulated by all 
hepatotoxic PA. This gene signature is summarized in Fig. 3. 
The genes regulated by individual PA are summarized in 
Table S2 in the supplemental material.
This list includes a high number of genes associated 
with DNA damage response; cell cycle control/integrity, or 
apoptosis: Rad51 recombinase (Rad51) plays an important 
role during homologous recombination and is upregulated. 
O-6-methylguanine-DNA methyltransferase (Mgmt) is 
involved in the repair of methylated DNA and is also upregu-
lated. Cyclin-dependent kinase inhibitor 1A (Cdkn1a) and 
Cyclin G1 (Ccng1) function as regulators of the cell cycle. 
Cdkn1a regulates cell cycle progression and leads to cell 
cycle G1 phase arrest. Ccgn1 is associated with DNA dam-
age-induced G2/M phase arrest. Both genes are regulated 
by the tumor suppressor protein p53 and were upregulated 
in this study. Upregulation of these genes suggests that PA 
may provoke DNA damage and, thus, induce expression of 
genes important for DNA repair and subsequent cell cycle 
control. The transcript for DNA damage-induced apoptosis 
suppressor (Ddias) was found to be upregulated; this may 
indicate a possible counter-regulation elicited to protect 
against DNA damage-induced cell death. MYB proto-onco-
gene like 2 (Mybl2) is a transcription factor that regulates 
cell cycle progression. Deregulation of Mybl2 expression 
is associated with cancer initiation and progression (Musa 
et al. 2017). Polo-like kinase 4 (Plk4) mediates duplication 
of centrioles during cell cycle and was also upregulated in 
Fig. 2  Comparison of dysregulated probe sets after oral treatment of 
male Fischer rats by gavage for 28 days with six different PA. Results 
for the high dose groups (3.3 mg/kg bw) are presented. a Clustering 
of gene expression changes in the liver following exposure to PA. 
Gene expression profiles were analyzed using Affymetrix microar-
rays. Rats were exposed to either 3.3 mg/kg bw echimidine (yellow), 
heliotrine (pink), lasiocarpine (red), senecionine (light blue), sen-
kirkine (green), platyphylline (orange) or a solution of 0.15 M NaCl 
serving as vehicle control (dark blue). Each column represents a sin-
gle animal. Each row shows a specific transcript. Microarray data 
were normalized, batch corrected and statistically analyzed using 
Qlucore Omics Explorer. A total of 284 probe sets were identified 
to be significantly differentially regulated (q < 0.05, ANOVA). Indi-
vidual PA exposure effects and fold changes were determined by per-
forming two-group comparison test versus the vehicle control. b The 
bar chart shows the average numbers of up- and downregulated probe 
sets for each treatment group. c The Venn diagram shows the average 
number of dysregulated probe sets for the different treatment groups 
(high dose groups with 3.3  mg/kg bw only) and their overlap. The 
Venn diagram was generated using https ://bioin forma tics.psb.ugent 
.be/webto ols/Venn/
▸
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this study. Minichromosome maintenance complex com-
ponent 5 (Mcm5) is important for DNA replication dur-
ing G1 and S phases of the cell cycle and was identified to 
be upregulated. Ribosomal protein L19 (Rpl19) is part of 
the 60S subunit of the ribosome and, thus, is essential for 
protein synthesis. Rpl19 was also among the upregulated 
common dysregulated genes. Upregulation of these three 
genes may point to replacement proliferation as a conse-
quence of cell death resulting from DNA damage. Induction 
of cell death is furthermore emphasized by upregulation of 
genes related to cell death: the Fas cell surface death recep-
tor (Fas) is involved in initiation of extrinsic apoptosis. An 
induction of apoptosis was also reported to be mediated by 
the ectodysplasin A2 receptor (Eda2r) (Sinha and Chaud-
hary 2004). BCL2-associated X (Bax) protein is another 
pro-apoptotic factor. Furthermore, several genes associated 
with transcriptional activity were identified as commonly 
dysregulated genes: ring finger proteins makorin ring finger 
protein 1 (Mkrn1) and ring finger protein 144A (Rnf144a) 
were downregulated, and ubiquitin like with PHD and ring 
finger domains 1 (Uhrf1) was upregulated. These three genes 
are associated with a novel class of zinc finger proteins that 
may act as transcriptional regulators. Putative homeodomain 
transcription factor 1 (Phtrf1) was downregulated. Finally, 
genes related to xenobiotic metabolism showed an altered 
expression upon treatment with PA: aldehyde dehydrogenase 
family 1 member A7 (Aldh1a7), aldehyde dehydrogenase 1 
family member A1 (Aldh1a1) and glutathione S-transferase 
alpha 1 (Gsta1) encode enzymes for xenobiotic metabolism 
and were all upregulated in this study. A total of 48 genes 
were individually regulated by only one single PA (listed in 
Supplementary Table S2). While the low number of indi-
vidual genes per PA does not allow concluding on specific 
mechanisms activated by only one of the test compounds, 
it is obvious that several genes are related to cell cycle, 
DNA repair or genotoxic responses, for example cyclin D1 
(Ccnd1), platelet-derived growth factor C (Pdgfc), KiSS-1 
metastasis suppressor (Kiss1), CD244 molecule (Cd244), 
caspase 12 (Casp12), or non-homologous end-joining factor 
1 (Nhej1), respectively.
Figure 4 depicts the dose dependence of significantly 
deregulated (q < 0.05) transcripts for each PA in a prin-
cipal component analysis (PCA) plot. The PCA shows 
that the highest dose (3.3 mg/kg bw) differs clearly from 
vehicle control among the main discriminate axis (PC1). 
A tendency of gene expression alterations compared to 
vehicle control was also observed for the second highest 
dose (1.0 mg/kg bw). These results suggest that 3.3 mg/kg 
Fig. 3  Fold change and classification of biological function of 36 
probe sets corresponding to 35 individual genes that are commonly 
dysregulated by all 5 toxic PA according to microarray data analy-
sis of livers of male Fischer rats orally treated daily for 28 days with 
3.3 mg/kg bw of the respective PA
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bw is a dose resulting in clear effects on the transcriptome 
of the liver, and that 1.0 mg/kg bw was in the borderline 
dose range near the NOEL for transcriptomic changes.
In case of platyphylline exposure, only the highest dose 
was analyzed. The PCA analysis of this group, therefore, 
displays a more pronounced discrimination along PC1, but 
of opposite direction compared to the other PA. Since unlike 
for the other PA no lower doses were analyzed, no conclu-
sions concerning dose response can be drawn for this PA.
Verification of microarray data
The expression levels of 4 upregulated and 3 downregulated 
genes were additionally assessed by qPCR. The transcripts 
for qPCR validation were randomly chosen from the set 
of significantly dysregulated genes (q < 0.05) which were 
directly affected by at least 3 of all toxic PA in the highest-
dose group. The gene expression pattern as analyzed by 
qPCR was similar to that of the microarray assay (see Sup-
plementary data Fig. S5), thus verifying the microarray data.
Ingenuity Pathway Analysis
IPA analysis was based on a subset of 284 signifi-
cantly (q < 0.05, ANOVA) dysregulated probe sets. For 
identification of a dose-dependent up- or downregulation of 
the transcripts, the correlation coefficient of a rank regres-
sion performed across all dose levels was uploaded to IPA. 
An IPA comparison analysis between all PA predicted 
affected canonical pathways, diseases and functions, and 
upstream regulators for the toxic PA echimidine, heliotrine, 
lasiocarpine, senecionine and senkirkine (Fig. 5). Platyphyl-
line as a non-toxic PA representative showed no predicted 
activation or inhibition of any of the analyzed functions. The 
canonical pathway analysis predominantly predicted interac-
tion with pathways related to DNA damage and cell cycle 
control/integrity (Fig. 5a).
IPA analysis found that ataxia telangiectasia mutated 
(ATM) signaling and tumor suppressor protein p53 sign-
aling show the highest activation z-score. ATM signaling 
was predicted to be activated by heliotrine, senecionine and 
senkirkine; p53 signaling was predicted to be activated by 
all PA except platyphylline. According to the IPA knowl-
edgebase (QIAGEN Inc., https ://www.qiage nbioi nform 
atics .com/produ cts/ingen uity-pathw ay-analy sis), both of 
these pathways are involved in initiation of DNA repair and 
able to lead to cell cycle arrest in the case of massive DNA 
damage. P53 furthermore regulates as a transcription fac-
tor the expression of several genes. Additionally, estrogen-
mediated S-phase entry (activated by heliotrine, senkirkine 
Fig. 4  Dose dependence of gene regulation for the different treat-
ment groups. For each PA, all tested doses were analyzed by one-way 
ANOVA. Differentially regulated genes (q < 0.05) were subjected 
to principal component analyses (PCA). Differences in dose-related 
effects are shown in the PCA plots with each individual animal being 
represented by a single dot
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and senecionine), G1/S checkpoint regulation (inactivated 
by heliotrine, senkirkine and senecionine), cyclins and cell 
cycle regulation (activated by heliotrine, senkirkine and 
senecionine), G2/M DNA damage checkpoint regulation 
(activated by senkirkine and senecionine), cell cycle regu-
lation by BTG family proteins (activated by senkirkine), and 
mitotic roles of polo-like kinase (activated by senkirkine 
and senecionine) were predicted to be regulated. All of 
these pathways are related to cell cycle regulation. PI3K/
AKT signaling was predicted to be activated by senkirkine. 
It regulates cell proliferation and cell death and is associ-
ated with cancer. Signaling by Rho family GTPases was 
predicted to be activated by heliotrine, senkirkine and sene-
cionine. Rho family GTPases are important for regulating 
signal transduction and, thus, involved in several cellular 
processes. Finally, aryl hydrocarbon receptor signaling was 
predicted to be inactivated. The aryl hydrocarbon receptor 
is a transcription factor which regulates the expression of 
several genes, e.g., relevant for xenobiotic metabolism, cell 
proliferation and, thus, cell cycle regulation.
Most predictions in the area of diseases and functions 
are associated with cell viability/cell death/cell cycle, DNA 
damage or carcinogenesis (Fig. 5b). These predictions point 
to a genotoxic effect accompanied by replacement prolif-
eration. Most of the predicted diseases and functions were 
affected by all PA except platyphylline. Platyphylline shows 
no impairment of any disease or biofunction.
Limiting the diseases and biofunctions predictions to 
hepatotoxicity only, resulted in predictions of functions 
related to liver cancer (Fig. 5c), such as stimulation of 
formation of liver tumor, hepatocellular carcinoma, liver 
cancer and liver carcinoma. Again, for platyphylline, no 
activation or inactivation of any hepatotoxic function was 
predicted.
IPA upstream analysis filtered for transcription regula-
tors identified several regulators associated with cell cycle 
control (Fig. 6). Cyclin D1 (Ccnd1) is involved in G1/S 
transition during cell cycle control and was activated by 
all analyzed PA, except platyphylline. Ccnd1 interacts 
with retinoblastoma protein (Rb/Rb1). Rb/Rb1 inhibits 
cell cycle progression and functions as a tumor suppres-
sor. Rb/Rb1 was downregulated on mRNA level by all 
PA (except platyphylline) pointing again to proliferation 
and possibly a promotion of cancer development. Rb/Rb1 
binds also to transcription factors of the E2f family leading 
to its inactivation. Transcription factors of the E2f family 
are also important for cell cycle progression. E2f1, E2f 
and E2f3 were predicted to be activated by all analyzed 
toxic PA. E2f6 was predicted to be inactivated by all PA, 
except lasiocarpine and platyphylline. Further activated 
transcription regulators, such as β-catenin, Foxm1, Irf1, 
Fig. 5  Biological functions 
and pathways predicted to be 
activated or inactivated by PA 
according to Ingenuity Pathway 
Analysis (IPA). A set of 284 
significantly (q < 0.05) dysregu-
lated rat liver transcripts was 
analyzed with IPA. Canonical 
pathways (a), diseases and bio-
functions (b) and hepatotoxic 
functions (c) are displayed. 
The heatmaps show activa-
tion z-scores for the respective 
canonical pathways. For dis-
eases and biofunctions, the 30 
diseases and functions with the 
highest positive or the lowest 
negative activation z-scores are 
shown. Hepatotoxic functions 
were identified by IPA analysis 
for activation/inactivation of 
diseases and functions, filtered 
for hepatotoxicity. A complete 
list of affected functions is 
presented in the supplemental 
material
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Myc, Mitf, Tbx2 with a somewhat lower z-score did also 
point to cell cycle regulation, DNA damage and cancer 
development.
Discussion
PA belong to the most widely distributed natural toxins 
known. However, there is still no in vivo study that includes 
human-relevant doses on the one hand and structure-depend-
ent hepatotoxicity on the other. Thus, our transcriptomic 
study aimed to investigate pathways affected by PA in a 
subacute animal study using exposure scenarios relevant for 
highly exposed humans. It was of particular interest whether 
the different PA show the same toxicity pattern or result 
in activation/inactivation of specific, individual pathways. 
Male Fischer rats were treated daily for 28 days orally with 
6 structurally different PA and gene expression in the liv-
ers was analyzed using whole-genome microarrays. A daily 
dose of 3.3 mg/kg bw was administered as the highest dose 
to exclude unspecific effects resulting from general toxicity. 
The amount of this maximum dose results from a two-week 
and 13-week NTP study with the cyclic retronecine type 
diester riddelliine in Fischer rats (NTP 2003). According 
to the publication of Merz and Schrenk (2016) riddelliine 
exhibits comparable potency like senecionine which was 
used in our study. We decided to choose senecionine as 
representative of aforementioned PA group due to a better 
comparison to an existing set of in vitro and in vivo data 
(Hessel-Pras et al. 2020; Hessel et al. 2014; Luckert et al. 
2015; Waizenegger et al. 2018). For comparing the highest 
dose used in our study to human exposure, human intake 
Fig. 6  Transcription regulators 
predicted to be activated/inac-
tivated by Ingenuity Pathway 
Analysis (IPA). A set of 284 
significantly (q < 0.05) dysregu-
lated rat liver transcripts was 
analyzed using IPA. Activation/
inactivation of upstream regula-
tors, filtered for transcription 
regulators, is displayed without 
using cutoffs. The heatmap 
shows the activation z-score 
for the respective regulator. 
The first 30 regulators with the 
highest positive or the lowest 
negative activation z-score are 
shown
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was estimated. Recently, a highly contaminated tea sample 
from the German retail market was found to contain 161 µg 
PA per tea bag (Stiftung Warentest 2017). Excluding PA 
uptake from other sources, such as herbal spices or honey, 
an average 60-kg adult who drinks 3 cups of this tea, would 
be exposed to 8-µg PA /kg bw. Therefore, the highest dose 
of 3.3 mg/kg bw used in the present study is about 400 times 
higher compared to the dose taken up by a human consum-
ing 3 cups of the aforementioned contaminated tea; while, 
the lowest tested dose of 0.1 mg/kg bw is approximately 
12.5-fold higher. A case report of infants describes that 
severe veno-occlusive disease was developed after inges-
tion of PA-contaminated food; the estimated daily PA uptake 
calculated from this report ranged from 0.8 to 3 mg/kg bw 
(Fox et al. 1978). The selected doses in this study, thus, rep-
resent a dose range that may be reached by human in worst 
case exposure scenarios. It should be noted that using higher 
doses of the compounds most probably would have provoked 
more pronounced transcriptional alterations. Nonetheless, 
this might have led to the masking of PA-specific effects 
by transcriptional signatures related to unspecific processes 
related to cell death and major organ damage. Therefore, 
the dosing was selected as described above, to allow for the 
detection of early transcriptional changes induced by PA.
Bioinformatic analysis identified a gene signature related 
to DNA damage, DNA repair, replacement proliferation/
impairment of cell cycle control. Also, the IPA analysis of 
diseases and functions, points to DNA repair, cell death and 
replacement proliferation. Upstream analysis filtered for 
transcription regulators identified additionally regulators 
that affect gene expression relevant for cell cycle progres-
sion/regulation, DNA damage response and cancer forma-
tion. Most of the identified dysregulated genes were affected 
by all 5 or at least 4 out of 5 toxic PA, indicating a similar 
mode of action. The genotoxic and carcinogenic potential 
of PA was already described in the literature. Merz and 
Schrenk (2016) furthermore list an overview about sev-
eral studies analyzing DNA damage, chromosomal damage 
and mutagenic effects induced by different PA. However, 
our study is not based on a classic 2-year carcinogenicity 
study, but on a transcriptomics approach with compara-
bly low doses of PA for a shorter period of 28 days. The 
results show that this approach identifies several dysregu-
lated genes that play a role in response to DNA damage 
and carcinogenesis at dose levels that may occur in humans 
in worst case scenarios. Recently, a toxicogenomics direc-
tory of 162 rat hepatotoxicants has been established that 
also contains a list of genes most frequently dysregulated 
by genotoxic and non-genotoxic rat carcinogens (Grinberg 
et al. 2018). These genes (Table S5 in Grinberg et al. 2018) 
show a high degree of overlap with the 35 genes shown to be 
deregulated by all 5 PA in the present study (Fig. 3). Among 
genes in the overlap of the present study and the consensus 
signature of Grinberg et al (2018) are Aldh1a1, Cdkn1a, 
Nr3c1, ERpl19, Mgmt, Fna, Clec4f, Ccng1, and Mybl2. No 
PA-induced effects were observed in the histopathological 
analysis; whereas, the transcriptomic approach showed clear 
alterations for the high-dose (3.3 mg/kg bw) PA groups. The 
second highest dose (1.0 mg/kg bw) seemed to be in a bor-
derline dose range where transcriptomics effects begin to be 
induced. Therefore, the results point to a higher sensitivity 
of a transcriptomics approach in comparison to conventional 
toxicity studies.
In our study, senecionine and senkirkine, both cyclic 
diesters of the retronecine or otonecine type, respectively, 
showed the strongest alterations compared to the vehicle 
control followed by heliotrine (monoester of the heliotridine 
type) and lasiocarpine (non-cyclic diester of the heliotri-
dine type). Echimidine (non-cyclic diester of the retrone-
cine type) fluctuated in the range of heliotrine and lasio-
carpine. Senecionine was identified before to belong to the 
most potent PA. Waizenegger et al. (2018) compared the 
cytotoxic and apoptotic potential of the four PA echimidine, 
heliotrine, senecionine and senkirkine in vitro in 24-h and 
14-day exposure scenarios. Senecionine showed the strong-
est effects followed by echimidine. Heliotrine and senkirkine 
showed much weaker effects. Louisse et al. (2019) inves-
tigated the genotoxic potential of 37 structurally different 
PA by analyzing the phosphorylation of the histone H2AX. 
According to their results, senecionine, lasiocarpine and 
echimidine show the highest toxic potential, followed by 
senkirkine and finally heliotrine. Merz and Schrenk (2016) 
suggested the introduction of relative potency factors for 
PA risk assessment. Their relative interim potency fac-
tors (iRPF) are based on the combined genotoxic potency 
in Drosophila, cytotoxic potency in vitro and acute toxic-
ity in adult rodents (i.p./i.v. injection). According to Merz 
and Schrenk, the PA senecionine, senkirkine and lasiocar-
pine belong to the most potent PA (iRPFs of 1.0), followed 
by heliotrine (iRPF 0.3) and echimidine (iRPF 0.1). The 
observations made in our study are very much in line with 
the suggested iRPFs. Some differences were observed for 
lasiocarpine, which showed a lower number of dysregulated 
genes compared to senecionine, senkirkine, echimidine and 
heliotrine. Compared to the results of Louisse et al. (2019), 
our results show a higher toxic potential for senkirkine and a 
lower toxic potential for echimidine and lasiocarpine. How-
ever, differences in potency can be due to the different test 
systems or exposure routes in the different studies. For the 
strong hepatotoxicity of PA, bioavailability and toxicokinetic 
properties most likely play a key role. Thus, our study com-
pares for the first time the induction of hepatotoxicity by six 
structurally different PA after an oral exposure representing 
the real exposure of humans. A different intestinal first pass 
effect and consequently different levels of liver toxicity can 
be assumed due to a different passage rate over the intestinal 
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barrier which was shown in vitro for four structurally dif-
ferent PA (Hessel et al. 2014). In Caco-2 cells, echimidine 
exhibited the lowest passage rate over the intestinal mon-
olayer due to an ABCB1-driven efflux. Due to structural 
similarities between echimidine and lasiocarpine (both open-
chain diester), the reduction of oral bioavailability by active 
efflux mechanisms can be hypothesized.
The analyzed gene signature points to DNA-damaging 
properties accompanied by replacement proliferation and 
cancer development. All analyzed hepatotoxic PA induced 
similar pathways. The effect strength depended on the 
respective PA structure type. Senecionine and senkirkine, 
both cyclic diesters of the retronecine and otonecine type, 
respectively, showed the strongest effect, followed by the 
non-cyclic diester of the retronecine type, echimidine, and 
the monoester of the heliotridine type, heliotrine. Lasiocar-
pine, a non-cyclic diester of the heliotridine type, induced 
comparably weak effects. Platyphylline, a PA representa-
tive assumed to be non-hepatotoxic, induced no relevant 
gene expression alterations, as expected. The detection 
of the DNA-damaging properties without observing his-
topathological changes (dose 1.0 mg PA per kg bw) and 
treatment duration far below classic carcinogenicity studies 
suggests that transcriptomic approaches may be a helpful 
tool to investigate the genotoxic potential of possible tox-
ins. While omics data represent promising approaches for 
the early, sensitive detection of certain toxic effects which 
become histopathologically detectable much later, there are 
still several obstacles which impede the use of omics data in 
a regulatory context. This includes, for example, harmoniza-
tion of technology platforms and data analysis workflows, 
as well as the definition of adversity (Marx-Stoelting et al. 
2015). Future research is, thus, still needed to facilitate the 
implementation of omics data in regulatory toxicology.
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